Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Harris, A. G.
Right arrow Articles by Netting, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, A. G.
Right arrow Articles by Netting, A. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 591-598
© 2000 The British Society for Antimicrobial Chemotherapy

Use of digoxigenin-labelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori

Andrew G. Harrisa, Stuart L. Hazellb,* and Andrew G. Nettingc

a School of Microbiology and Immunology, University of New South Wales, Sydney 2052, NSW; b Department of Biological Sciences, Faculty of Informatics, Science and Technology, University of Western Sydney, Macarthur, PO Box 555, Campbelltown 2560, NSW; c School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney 2052, NSW, Australia

Amoxycillin is used in current therapeutic regimens to treat the infection caused by the human gastric pathogen, Helicobacter pylori. The penicillin-binding proteins (PBPs) are the primary targets for the ß-lactam antibiotics, such as amoxycillin, and are involved in the terminal stages of peptidoglycan synthesis. They also play active roles in the determination and maintenance of cellular morphology. It was believed that an organism with a complex morphology, such as H. pylori, would have more than the three PBPs previously suggested. Using digoxigenin-labelled ampicillin (DIG-ampicillin), we report the identification of eight PBPs in H. pylori with masses of 72, 62, 54, 50, 44, 33.5, 30.5 and 28 kDa. A smaller (21 kDa) ninth band was also detected, which may represent another PBP. However, the relatively small size of this apparent PBP raises questions as to whether this is a true PBP. In an attempt to identify the PBPs to which amoxycillin preferentially binds, amoxycillin was used in competition assays with DIG-ampicillin. It appeared that amoxycillin inhibited the binding of DIG-ampicillin to only the 72 kDa PBP. The experimental data were also compared with the seven putative PBPs identified in the two published H. pylori genomes, most of which correlate with the experimental data. To investigate further the properties of these PBPs, the seven putative PBP genes identified in the H. pylori genomes were examined. The derived amino acid sequences of the putative PBPs were examined for the three characteristic motifs found in all conventional PBPs, SXXK, SXN and KTG. We were able to determine that all of the putative PBPs had at least one of these motifs, but none possessed all three motifs with the characteristics of conventional PBPs. These findings suggest that the PBPs of H. pylori are unique.

* Corresponding author. Tel: +61-2-4620-3242; Fax: +61-2-4620-3793; E-mail: s.hazell{at}uws.edu.au


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
E.-M. A. Co and N. L. Schiller
Resistance Mechanisms in an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori
Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4174 - 4176.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. P. Dassanayake, G. Sarath, and G. E. Duhamel
Penicillin-Binding Proteins in the Pathogenic Intestinal Spirochete Brachyspira pilosicoli
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1561 - 1563.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. H. Kwon, M. P. Dore, J. J. Kim, M. Kato, M. Lee, J. Y. Wu, and D. Y. Graham
High-Level {beta}-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2169 - 2178.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
A. G. Harris, J. E. Wilson, S. J. Danon, M. F. Dixon, K. Donegan, and S. L. Hazell
Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model
Microbiology, March 1, 2003; 149(3): 665 - 672.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
T. Okamoto, H. Yoshiyama, T. Nakazawa, I.-D. Park, M.-W. Chang, H. Yanai, K. Okita, and M. Shirai
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori
J. Antimicrob. Chemother., December 1, 2002; 50(6): 849 - 856.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. M. Gerrits, D. Schuijffel, A. A. van Zwet, E. J. Kuipers, C. M. J. E. Vandenbroucke-Grauls, and J. G. Kusters
Alterations in Penicillin-Binding Protein 1A Confer Resistance to {beta}-Lactam Antibiotics in Helicobacter pylori
Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2229 - 2233.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. H. Cassell and J. Mekalanos
Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic Resistance
JAMA, February 7, 2001; 285(5): 601 - 605.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. R. DeLoney and N. L. Schiller
Characterization of an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori
Antimicrob. Agents Chemother., December 1, 2000; 44(12): 3368 - 3373.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.